0002137361-26-000001.txt : 20260527 0002137361-26-000001.hdr.sgml : 20260527 20260527165040 ACCESSION NUMBER: 0002137361-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260527 DATE AS OF CHANGE: 20260527 EFFECTIVENESS DATE: 20260527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Monocacy Therapeutics Inc. CENTRAL INDEX KEY: 0002137361 ORGANIZATION NAME: EIN: 412998999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-585336 FILM NUMBER: 261027115 BUSINESS ADDRESS: STREET 1: 4716 MONROVIA BLVD CITY: MONROVIA STATE: MD ZIP: 21770 BUSINESS PHONE: 3019790911 MAIL ADDRESS: STREET 1: 4716 MONROVIA BLVD CITY: MONROVIA STATE: MD ZIP: 21770 D 1 primary_doc.xml X0708 D LIVE 0002137361 Monocacy Therapeutics Inc. 4716 MONROVIA BLVD MONROVIA MD MARYLAND 21770 3019790911 DELAWARE None None Corporation true 2025 Suman Vodnala 2835 Crusader Street Alameda CA CALIFORNIA 94501 Executive Officer Director Cofounder, Secretary and Chief Innovation Officer Biotechnology Decline to Disclose 06b false 2026-05-05 true true Simple Agreement for Future Equity (SAFE)? false 10000 Indefinite 114450 Indefinite true 1 2 0 0 0 false Monocacy Therapeutics Inc. SJPatel Shashankkumar Patel President and CEO 2026-05-27